Business
Earth Science Tech, Inc. (ETST) Achieves Fully Reporting Status with the SEC under the Exchange Act of 1934
Earth Science Tech, Inc. (ETST) Achieves Fully Reporting Status with the SEC under the Exchange Act of 1934.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\nDORAL, Florida, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST\" or the “Company\"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces a Form 10 filing effective date, making the Company fully reporting with the Security Exchange Commission (SEC).\n As anticipated, the Company’s Form 10 Registration Statement is officially effective as of August 29, 2018, by the SEC. Following the effective date, ETST will be subject to the reporting requirements of the Exchange Act of 1934, as amended. This means the Company will begin filing annual reports with the SEC on Form 10-k, quarterly reports on Form 10-Q, periodic reports on Form 8-k, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules. “With our Form 10 filing now effective, ETST is progressing towards fulfilling its goals,” states Earth Science Tech president, director and Chairman Nickolas S. Tabraue. “Following this achievement, we anticipate to up-list to the OTCQB tier in early September, due to our early application submission with OTC Markets Group, Inc. We look forward to maximizing the value of our company for our loyal shareholders as we unfold.” About Earth Science Tech, Inc. (ETST) Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. To learn more, please visit: www.EarthScienceTech.com ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors: Earth Science Pharmaceutical, Inc. Earth Science Pharmaceutical (\"ESP\") is a wholly o...